Newsletter June 2022
Abstract
Editors’ Choice in June 2022:
Tofacitinib for Treatment of Alopecia Areata: Real-world Evidence and Factors Associated with Therapeutic Response
Manuel Sanchez-Diaz, Pablo Diaz-Calvillo, Juan-Angel Rodriguez-Pozo, Jesús Tercedor-Sánchez, Maria-Rosa Cantudo-Cuenca, Alejandro Molina-Leyva, Salvador Arias-Santiago
Further highlights of June 2022:
Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab.
Shoko Miyamoto, Yasutomo Imai, Masaru Natsuaki, Kiyofumi Yamanishi, Nobuo Kanazawa
Chlormethine Gel is Efficient and Safe in Mycosis Fungoides Skin Lesions.
Marios Koumourtzis, Kyriaki Lampadaki, Maria Dalamaga, Evangelia Papadavid
Evaluating the Effectiveness of Intranasal Butorphanol in Reducing Chronic Itch.
Angelina Labib, Teresa Ju, Zoe Morgan Lipman, Gil Yosipovitch
Differences in Occurrence, Risk Factors and Severity of Early-onset Atopic Dermatitis among Preterm and Term Children.
Trine Gerner, Maria Rasmussen Rinnov, Anne-Sofie Halling, Nina Haarup Ravn, Mette Hjorslev Knudgaard, Caroline Ewertsen, Simon Trautner, Ivone Jakasa, Sanja Kezic, Lone Skov, Jacob P. Thyssen
Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma: A Retrospective Study.
Florian Herms, Barouyr Baroudjian, Julie Delyon, Pauline Laly, Pauline Tetu, Celeste Lebbe, Nicole Basset-Seguin
Real-world Methotrexate Use in a Prospective Cohort of Paediatric Patients with Plaque Psoriasis: Effectiveness, Adverse Events and Folic Acid Regimen.
Finola M. Bruins, Maartje R. van Acht, Inge M.G.J. Bronckers, Hans M.M. Groenewoud, Elke M.G.J. de Jong, Marieke M.B. Seyger
Downloads
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
